{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/06/13/3311366/0/en/Belite-Bio-Completes-Rolling-Submission-of-New-Drug-Application-to-U-S-Food-and-Drug-Administration-for-Tinlarebant-for-the-Treatment-of-Stargardt-Disease-Type-1.html", "message": "News view counter 798370 successfully enlarged"}